This special feature is brought to you by the Science/AAAS Custom Publishing Office

New Product

Liquid Biopsy Kit

Expedeon

For info: +44-(0)-1223-873364
Expedeon

TruePrime LB addresses current liquid biopsy sensitivity and specificity issues by using adapted amplification of cancer-specific, large-fragment, cell-free DNA based on primer-free technology that combines the enzymes TthPrimPol and Phi29 DNA polymerase. TruePrime-mediated circulating tumor DNA amplification specifically selects the larger, more cancer-specific DNA fragment-size population from human plasma. Consequently, TruePrime LB provides a method for assessing cancer genome information from all patients, regardless of tumor burden, with superior sensitivity and specificity. The kit also preserves the single-nucleotide variants (SNVs) and SNV frequencies across different sequencing technologies and allows the amplification of cell-free DNA to levels that permit sequencing. TruePrime LB offers a screening method for de novo detection of cancer or reoccurrence of cancer based on a threshold of amplified DNA obtainable within a certain reaction time frame.

Custom Publishing

Read all of the best Custom Publishing content from Science. Visit our Custom Publishing section for special collections, tech features, posters and more.

Custom Publishing